Efstathios Vassiliadis

[:pl]Efstathios Vassiliadis[:]



CEO of OARK and Evnia Group, he has a dual R&D and business background (PhD, MSc from Kings College London, SDU-Denmark, MBA from Bradford University), and more than 17 years of experience in Biotech & Pharma in USA and Europe, with multi-disciplinary projects involving compliance, R&D and cross-functional senior management. He holds 11 international patents, and have launched numerous products to FDA/EMA clearance. He holds an editorial board in several international scientific journals.